Your browser doesn't support javascript.
loading
Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units.
Choi, Peter J; Sutherland, Hamish S; Tong, Amy S T; Blaser, Adrian; Franzblau, Scott G; Cooper, Christopher B; Lotlikar, Manisha U; Upton, Anna M; Guillemont, Jerome; Motte, Magali; Queguiner, Laurence; Andries, Koen; Van den Broeck, Walter; Denny, William A; Palmer, Brian D.
Afiliação
  • Choi PJ; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
  • Sutherland HS; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
  • Tong AST; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
  • Blaser A; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
  • Franzblau SG; Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA.
  • Cooper CB; Global Alliance for TB Drug Development, 40 Wall St, New York 10005, USA.
  • Lotlikar MU; Global Alliance for TB Drug Development, 40 Wall St, New York 10005, USA.
  • Upton AM; Global Alliance for TB Drug Development, 40 Wall St, New York 10005, USA.
  • Guillemont J; Medicinal Chemistry Department (Infectious Diseases), Janssen Pharmaceuticals, Campus de Maigremont, BP315, 27106 Val de Reuil Cedex, France.
  • Motte M; Medicinal Chemistry Department (Infectious Diseases), Janssen Pharmaceuticals, Campus de Maigremont, BP315, 27106 Val de Reuil Cedex, France.
  • Queguiner L; Medicinal Chemistry Department (Infectious Diseases), Janssen Pharmaceuticals, Campus de Maigremont, BP315, 27106 Val de Reuil Cedex, France.
  • Andries K; Janssen Infectious Diseases BVBA, Beerse, Belgium.
  • Van den Broeck W; Janssen Infectious Diseases BVBA, Beerse, Belgium.
  • Denny WA; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Electronic address: b.denny@auckland.ac.nz.
  • Palmer BD; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Bioorg Med Chem Lett ; 27(23): 5190-5196, 2017 12 01.
Article em En | MEDLINE | ID: mdl-29107541
ABSTRACT
Analogues of bedaquiline where the phenyl B-unit was replaced with monocyclic heterocycles of widely differing lipophilicity (thiophenes, furans, pyridines) were synthesised and evaluated. While there was an expected broad positive correlation between lipophilicity and anti-TB activity, the 4-pyridyl derivatives appeared to have an additional contribution to antibacterial potency. The majority of the compounds were (desirably) more polar and had higher rates of clearance than bedaquiline, and showed acceptable oral bioavailability, but there was only limited (and unpredictable) improvement in their hERG liability.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Diarilquinolinas / Compostos Heterocíclicos / Antituberculosos Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Lett Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Diarilquinolinas / Compostos Heterocíclicos / Antituberculosos Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Lett Ano de publicação: 2017 Tipo de documento: Article